Steven R. Rousey

497 citations
20 papers · 391 indexed · h-index 10

Steven R. Rousey

20 papers receiving 377 citations

Peers

Steven R. Rousey
Comparison fields: 5 of 67
  • Infectious Diseases 96
  • Oncology 140
  • Microbiology 3
  • Hematology 41
  • Pulmonary and Respiratory Medicine 118
Replace M. Macpherson with:
M. Macpherson United Kingdom
Hyunkyung Park South Korea
Puo‐Hsien Le Taiwan
S. Thongprasert United States
William M. O’Neil Canada
Sam Khorrami Spain
Urban Sjöqvist Sweden
Fang Yuan China
Varun Garg United States
Abbe Rubin United States
Steven R. Rousey relative to M. Macpherson United Kingdom M. Macpherson's profile →
Citations per field
00.5×1.5×2.4×
M. Macpherson · 1×
Citations per year

Countries citing papers authored by Steven R. Rousey

Since Specialization
Citations

This map shows the geographic impact of Steven R. Rousey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Rousey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Rousey more than expected).

Fields of papers citing papers by Steven R. Rousey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Rousey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Rousey. The network helps show where Steven R. Rousey may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven R. Rousey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven R. Rousey Line = papers co-authored together Steven R. Rousey links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20172
2 20168
3 20157
4 201427
5 20131
6 201212
7 201223
8 20101
9 201033
10 200944
11 20086
12 20081
13 20072
14 200611
15 200656
16
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
200615
17 200517
18 1991116
19 19908
20 19851

About Steven R. Rousey

Steven R. Rousey is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Oncology, having authored 20 papers that have together received 391 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Ginseng Biological Effects and Applications (2 papers), Renal cell carcinoma treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer Treatment and Pharmacology (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Infectious Diseases (96 citations), Oncology (140 citations) and Microbiology (3 citations). Steven R. Rousey has collaborated with scholars based in United States and Canada. Frequent co-authors include Robert C. Ash, Mark S. Gottlieb, Lina Asmar, Kristi A. Boehm, Catherine Craig, Linus Ho, James C. Yao, Jaffer A. Ajani, Ralph E. Weinstein and Yixing Jiang. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Medicine and Reproduction.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026